Published in Int J Radiat Oncol Biol Phys on August 01, 2003
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys (2007) 2.34
Recent advances in radiotherapy. BMC Med (2010) 1.43
Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol (2006) 1.04
Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies. Front Oncol (2012) 1.03
Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer. Gynecol Oncol (2013) 0.94
The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future. Rep Pract Oncol Radiother (2013) 0.90
Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis. Radiat Oncol (2012) 0.87
Whole pelvic intensity-modulated radiotherapy for gynecological malignancies: A review of the literature. Crit Rev Oncol Hematol (2015) 0.83
Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer. Oncol Hematol Rev (2012) 0.83
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol (2006) 0.82
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative intensity modulated radiotherapy for early-stage cervical cancer. BMC Cancer (2014) 0.81
Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma. Onco Targets Ther (2012) 0.81
Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer. Radiat Oncol (2015) 0.81
Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Radiat Oncol (2015) 0.80
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control. J Exp Clin Cancer Res (2013) 0.79
Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity. Radiat Oncol (2010) 0.78
Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report. Rep Pract Oncol Radiother (2015) 0.78
Late GI and bladder toxicities after radiation for uterine cancer. Gynecol Oncol (2010) 0.78
Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan. J Gynecol Oncol (2016) 0.77
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature. Oncol Lett (2014) 0.77
3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: the Shanghai Cancer Hospital experience. PLoS One (2012) 0.77
Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging (2006) 0.77
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol (2013) 0.77
Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning. Radiat Oncol (2010) 0.77
Internal target volume for post-hysterectomy vaginal recurrences of cervical cancers during image-guided radiotherapy. Br J Radiol (2015) 0.75
Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review. Oncol Lett (2016) 0.75
An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography. Mol Clin Oncol (2015) 0.75
Global radiation oncology waybill. Rep Pract Oncol Radiother (2013) 0.75
Should we customize PTV expansions for BMI? Daily cone beam computerized tomography to assess organ motion in postoperative endometrial and cervical cancer patients. Rep Pract Oncol Radiother (2016) 0.75
Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques. Curr Oncol (2015) 0.75
Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment. PLoS One (2016) 0.75
Interstitial brachytherapy guided intensity modulated radiation therapy (IBGIMRT) in cervical cancer: a dosimetric study. J Contemp Brachytherapy (2009) 0.75
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol (2007) 2.44
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys (2007) 2.34
Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys (2002) 2.03
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.89
Population-based study of competing mortality in head and neck cancer. J Clin Oncol (2011) 1.82
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. J Nucl Med (2003) 1.76
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys (2010) 1.73
A survey of stereotactic body radiotherapy use in the United States. Cancer (2011) 1.71
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.62
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. J Nucl Med (2010) 1.61
Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys (2002) 1.61
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys (2008) 1.57
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys (2004) 1.52
A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys (2006) 1.50
Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.46
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2014) 1.39
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2010) 1.25
Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.22
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol (2009) 1.16
Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract (2013) 1.13
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys (2012) 1.12
A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol (2003) 1.11
A survey of image-guided radiation therapy use in the United States. Cancer (2010) 1.10
Calculation and prediction of the effect of respiratory motion on whole breast radiation therapy dose distributions. Med Dosim (2008) 1.03
Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst (2013) 1.02
Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys (2012) 1.01
The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer (2012) 1.00
Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis. BMC Cancer (2003) 0.99
Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol (2009) 0.97
Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.97
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer (2008) 0.96
A survey of intensity-modulated radiation therapy use in the United States. Cancer (2003) 0.94
Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys (2010) 0.93
Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer (2014) 0.92
Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys (2012) 0.92
Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol (2010) 0.92
A hybrid approach to reducing computed tomography metal artifacts in intracavitary brachytherapy. Brachytherapy (2005) 0.92
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2008) 0.91
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol (2005) 0.91
Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer (2013) 0.90
Linac-based intensity modulated total marrow irradiation (IM-TMI). Technol Cancer Res Treat (2006) 0.88
Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer? Counterpoint. Brachytherapy (2002) 0.87
More on cetuximab in head and neck cancer. N Engl J Med (2007) 0.87
Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys (2008) 0.86
Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosim (2002) 0.84
Survey of resident education in intensity-modulated radiation therapy. Technol Cancer Res Treat (2005) 0.83
Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys (2010) 0.82
Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. Am J Clin Oncol (2016) 0.82
Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys (2005) 0.81
Characterization of a novel phantom for three-dimensional in vitro cell experiments. Phys Med Biol (2009) 0.81
Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hematol Oncol (2006) 0.81
Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys (2010) 0.81
Setup errors in patients treated with intensity-modulated whole pelvic radiation therapy for gynecological malignancies. Med Dosim (2005) 0.80
Optimized planning target volume for intact cervical cancer. Int J Radiat Oncol Biol Phys (2012) 0.80
Feasibility study on dosimetry verification of volumetric-modulated arc therapy-based total marrow irradiation. J Appl Clin Med Phys (2013) 0.80
Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesis. Int J Radiat Oncol Biol Phys (2012) 0.80
A system for continual quality improvement of normal tissue delineation for radiation therapy treatment planning. Int J Radiat Oncol Biol Phys (2012) 0.79
Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol (2013) 0.79
Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials (2012) 0.78
Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans. Med Dosim (2004) 0.78
Intensity-modulated radiation therapy for prostate cancer. Clin Prostate Cancer (2003) 0.78
Intensity-modulated radiation therapy in gynecologic malignancies. Curr Treat Options Oncol (2004) 0.78
A segmentation and point-matching enhanced efficient deformable image registration method for dose accumulation between HDR CT images. Phys Med Biol (2015) 0.77
Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys (2010) 0.77
Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys (2010) 0.77
Cell detection in phase-contrast images used for alpha-particle track-etch dosimetry: a semi-automated approach. Phys Med Biol (2005) 0.76
Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?". Gynecol Oncol (2003) 0.75
A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol (2011) 0.75
How does TPF improve survival over PF? Lancet Oncol (2011) 0.75
Implementation of electronic checklists in an oncology medical record: initial clinical experience. J Oncol Pract (2011) 0.75
Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol (2010) 0.75
Characterization of an alpha-particle irradiator for individual cell dosimetry measurements. Cancer Biother Radiopharm (2003) 0.75
Intensity-modulated radiotherapy and the Internet. Cancer (2004) 0.75
Validation of temporal optimization effects for a single fraction of radiation in vitro. Int J Radiat Oncol Biol Phys (2009) 0.75
Optimization of the temporal pattern of radiation: an IMRT based study. Int J Radiat Oncol Biol Phys (2006) 0.75
A survey on table tolerances and couch overrides in radiotherapy. J Appl Clin Med Phys (2016) 0.75
Binary methods for the microdosimetric analysis of cell survival data from alpha-particle irradiation. Cancer Biother Radiopharm (2003) 0.75
Simulation of binary methods for the microdosimetric analysis of cell survival after alpha-particle irradiation: ability to distinguish between different models. Radiat Res (2004) 0.75